UBS AM
PRVA icon

UBS AM’s Privia Health PRVA Stock Holding History

UBS AM’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.1M Sell
1,948,021
-103,638
-5% -$2.4M 0.01% 661
2026
Q1 		$42.2M Sell
2,051,659
-37,435
-2% -$844K 0.01% 662
2025
Q4 		$49.5M Sell
2,089,094
-76,261
-4% -$1.86M 0.01% 607
2025
Q3 		$53.9M Buy
2,165,355
+55,944
+3% +$1.2M 0.01% 592
2025
Q2 		$48.5M Sell
2,109,411
-523,629
-20% -$12.1M 0.01% 710
2025
Q1 		$59.1M Buy
2,633,040
+1,693,870
+180% +$39.4M 0.02% 653
2024
Q4 		$18.4M Buy
939,170
+114,647
+14% +$2.27M ﹤0.01% 989
2024
Q3 		$15M Sell
824,523
-5,461
-0.7% -$104K ﹤0.01% 1061
2024
Q2 		$14.4M Buy
829,984
+698,840
+533% +$12.4M ﹤0.01% 989
2024
Q1 		$2.57M Buy
131,144
+10,238
+8% +$216K ﹤0.01% 1554
2023
Q4 		$2.78M Buy
120,906
+6,119
+5% +$137K ﹤0.01% 1521
2023
Q3 		$2.64M Buy
114,787
+16,408
+17% +$417K ﹤0.01% 1484
2023
Q2 		$2.72M Hold
98,379
– – ﹤0.01% 1513
2023
Q1 		$2.72M Buy
98,379
+13,057
+15% +$345K ﹤0.01% 1513
2022
Q4 		$1.94M Buy
85,322
+1,532
+2% +$42.6K ﹤0.01% 1539
2022
Q3 		$2.85M Buy
83,790
+12,479
+17% +$461K ﹤0.01% 1415
2022
Q2 		$2.08M Buy
71,311
+5,621
+9% +$143K ﹤0.01% 1600
2022
Q1 		$1.76M Buy
+65,690
New +$1.55M ﹤0.01% 1858

Other funds holding PRVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

UBS AM's PRVA Position: Q2 2026 in Review

UBS AM reduced its Privia Health (PRVA) stake by 5.1% in Q2 2026, selling an estimated $2.4M and leaving 1,948,021 shares worth $50.1M. The position accounts for 0.01% of the portfolio, ranked #661.

UBS AM first reported a position in PRVA in Q1 2022 and has held it in 18 quarters since. The position peaked at $59.1M in Q1 2025. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • UBS AM held 1,948,021 shares of Privia Health worth $50.1M as of Q2 2026.
  • UBS AM sold 103,638 Privia Health shares in Q2 2026, an estimated $2.4M.
  • Privia Health made up 0.01% of UBS AM's portfolio in Q2 2026, its #661 holding.
  • UBS AM first reported a position in Privia Health in Q1 2022 and has held it in 18 quarters since.
  • UBS AM's Privia Health position peaked at $59.1M in Q1 2025.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.